SCHEDULE: Todd Fennell Reports 10.2% Stake in Prothena Corp

Todd W. Fennell has reported beneficial ownership of approximately 10.2% of Prothena Corp's ordinary shares, primarily through various trusts.

Summary

• Todd W. Fennell has filed a Schedule 13G, reporting beneficial ownership of 5,248,846 Ordinary Shares of Prothena Corp Public Ltd Co.
• This holding represents approximately 10.2% of the company's outstanding shares as of July 30, 2026.
• The shares are held through various trusts where Mr. Fennell serves as an independent trustee.
• Specifically, 215,000 shares are held by various trusts, and 5,033,846 shares are held by grantor retained annuity trusts.
• Mr. Fennell disclaims beneficial ownership of shares where he does not have a pecuniary interest and denies being part of a group.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting on beneficial ownership changes without significant new financial or strategic information.

Positives

• Clear disclosure of significant beneficial ownership by Todd W. Fennell.
• The filing indicates a substantial holding of 10.2% in Prothena Corp.

Negatives

• The filing does not provide new financial performance data or strategic updates.
• The nature of the trusts holding the shares may limit direct control or pecuniary interest for Mr. Fennell.

Risks

• Potential for future changes in beneficial ownership that could impact share price.
• The reliance on trusts for shareholding could introduce complexities in governance or decision-making.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it is a disclosure of beneficial ownership.

Management Comments

• "The Reporting Person may be deemed to be the beneficial owner of 5,248,846 Ordinary Shares."
• "The Reporting Person disclaims beneficial ownership of all Ordinary Shares to which the Reporting Person does not have a pecuniary interest, and the Reporting Person expressly disclaims any status as a group with any other party."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant individual shareholders to report their holdings. This filing indicates a notable stake in Prothena Corp, a biotechnology company focused on developing therapies for rare diseases.

Stakeholder Impact

• Shareholders: The disclosure of a significant ownership stake may influence investor perception and trading activity.
• Management: May be aware of a substantial shareholder's position, potentially impacting strategic discussions.

Next Steps

• Continued monitoring of Todd W. Fennell's beneficial ownership in Prothena Corp.
• Observation of any future filings that may indicate changes in this ownership stake.

Key Dates

Keywords

Prothena Corp, Todd W. Fennell, Schedule 13G, Beneficial Ownership, Ordinary Shares, Trusts, Investment Holding